Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(4)
MIXED(1)
Pemetrexed + Cisplatin /Carboplatin
1 trial
phase_2_3
eikon-therapeutics-inc
Nab-paclitaxel + Carboplatin
1 trial
phase_2_3
eikon-therapeutics-inc
Paclitaxel + Carboplatin
1 trial
phase_2_3
eikon-therapeutics-inc
Pembrolizumab (KEYTRUDA®)
1 trial
phase_2_3
eikon-therapeutics-inc
EIK1001
1 trial
phase_2_3
eikon-therapeutics-inc
5 unique interventions2 categories

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Recruiting1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT07365319Phase 2/3Recruiting
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Non Small Cell Lung Cancer (Squamous or Non Squamous)Stage 4 NSCLC
StudydirectorStart date: 2026-06-15

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

3 similar investigators found

David PLANCHARD, MD, PHD

Gustave Roussy, Cancer Campus, Grand Paris

Related
1 trials

Shared therapeutic areas:

Non Small Cell Lung Cancer (Squamous or Non Squamous)
Similarity Score10%

Elias Sayour, MD, PhD

University of Florida

Related
5 trials

Shared therapeutic areas:

Stage 4 NSCLC
Similarity Score10%

Steven Lin, MD, PhD

M.D. Anderson Cancer Center

Related
1 trials

Shared therapeutic areas:

Stage 4 NSCLC
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT07365319Phase 2/3StudyDirector

A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

Non Small Cell Lung Cancer (Squamous or Non Squamous)Stage 4 NSCLC
Recruiting

All 1 trials loaded